Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2017

Open Access 01-12-2017 | Letter

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

Authors: Gerardo Aguilar, Rafael Ferriols, Angels Lozano, Carlos Ezquer, José A. Carbonell, Ana Jurado, Juan Carrizo, Ferran Serralta, Jaume Puig, David Navarro, Manuel Alos, F. Javier Belda

Published in: Critical Care | Issue 1/2017

Login to get access

Excerpt

The aim of the present study was to describe the pharmacokinetics of caspofungin in 12 critically ill adult patients with suspected or proven invasive candidiasis who were receiving continuous venovenous hemodiafiltration (CVVHD). …
Literature
1.
Weiler S, Seger C, Pfisterer H, et al. Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. Antimicrob Agents Chemother. 2013;57(8):4053–7.CrossRef
2.
Leitner JM, Meyer B, Fuhrmann V, et al. Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration. J Antimicrob Chemother. 2011;66(4):880–4.CrossRef
3.
Gonzalez de Molina F, Martinez-Alberici Mde L, Ferrer R. Treatment with echinocandins during continuous renal replacement therapy. Crit Care. 2014;18(2):218.CrossRef
4.
Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drugs in fungal infections: a comparison. Drugs. 2011;71:11–41.CrossRef
5.
Andes D, Ambrose PG, Hammel JP, et al. Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia. Antimicrob Agents Chemother. 2011;55(5):2113–21.CrossRef
Metadata
Title
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
Authors
Gerardo Aguilar
Rafael Ferriols
Angels Lozano
Carlos Ezquer
José A. Carbonell
Ana Jurado
Juan Carrizo
Ferran Serralta
Jaume Puig
David Navarro
Manuel Alos
F. Javier Belda
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2017
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-016-1594-9

Other articles of this Issue 1/2017

Critical Care 1/2017 Go to the issue

Review

Novel insights in ICU-acquired respiratory muscle dysfunction: implications for clinical care

Research

Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry

Review

Neuroanatomy of sepsis-associated encephalopathy

Research

Clonidine for sedation in the critically ill: a systematic review and meta-analysis

Review

Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice

Research

Retinal arterial blood flow and retinal changes in patients with sepsis: preliminary study using fluorescein angiography